CINN’s Nanomedicine research group was established in 2015 as a result of the center’s increased activity in the biomedical field.
The ongoing research lines are focused on five main areas:
- Application of next generation technologies in the search for epigenetic biomarkers related to aging and human tumorigenesis which are useful in clinical practice.
- Identification of epigenetic changes in response to nanomaterials, and especially to graphene and graphenic nanomaterials.
- Development of nanocarriers for epigenetic antitumor drug delivery.
- Novel inorganic antimicrobial products.
Tissue engineering: Solutions to avoid peri-implantitis, ceramic materials for long-lasting implants, bone scaffolds, etc.